p53 genotypes and haplotypes associated with risk of breast cancer

Cancer Detection and Prevention

Volumn 31, Issue 3, 2007, Pages 207-213

  Buyru, Nur ^a   Altinisik, Julide ^a   Demokan, Semra ^b   Dalay, Nejat ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Breast cancer risk; DNA repair; Functional p53 polymorphisms; Genotype combinations; Haplotype frequencies; p53; Single nucleotide changes

Indexed keywords

ARGININE; PROTEIN P53;

ADULT; ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; CORRELATION COEFFICIENT; DATA ANALYSIS; DNA DETERMINATION; DNA ISOLATION; EXON; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; KOLMOGOROV SMIRNOV TEST; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; TUMOR SUPPRESSOR GENE;

ADULT; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EXONS; FEMALE; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTRONS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK; TURKEY;

EID: 34547840251     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.04.004     Document Type: Article

References (44)

1. Harris C.C. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 253 (1991) 49-53
2. Vogelstein B., and Kinzler K.W. p53 function and dysfunction. Cell 70 (1992) 523-526
3. Roy B., Beaman J., Balint E., and Reisman D. Transactivation of the human p53 tumor suppressor gene by c-myc/max contributes to elevated mutant p53 expression in some tumors. Mol Cell Biol 14 (1994) 7805-7815
4. Hainaut P., Soussi T., Shomer B., Hollstein M., Greenblatt M., Hovig E., et al. Database of p53 gene somatic mutations in human tumors cell lines: updated compliation and future prospects. Nucleic Acids Res 25 (1997) 151-157
5. Lozano G., and Levine A.J. Tissue-specific expression of p53 in transgenic mice is regulated by intron sequences. Mol Carcinog 4 (1991) 3-9
6. Hahn M., Serth J., Fislage R., Wolfes H., Allhoff F., Jonas V., et al. Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene. Clin Chem 39 (1993) 549-550
7. Ito T., Seyama T., Hayashi T., Mizuno T., Iwamoto K.S., Tsuyama N., et al. Hae III polymorphism in intron 1 of the human p53 gene. Hum Genet 93 (1994) 222
8. Peller S., Kopilova Y., Slutzki S., Halevy A., Kvitko K., and Rotter V. A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. DNA Cell Biol 14 (1995) 983-990
9. Buller R.E., Skilling J.S., Kaliszewski S., Niemann T., and Anderson B. Absence of significant germ line p53 mutations in ovarian cancer patients. Gynecol Oncol 58 (1995) 368-374
10. Chumakov P.M., and Jenkins J.R. BstNI/NciI polymorphism of the human p53 gene (TP53). Nucleic Acids Res 19 (1991) 6969
11. Prosser J., and Candic A. Biallelic Apa I polymorphism of the human p53 gene (TP53). Nucleic Acids Res 19 (1991) 4799
12. Runnebaum I.B., Tong X.W., Moebus V., Heilman V., Kreback D.G., and Kreinberg R. Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines. Hum Genet 93 (1994) 620-624
13. Lazar V., Hazard F., Bertin F., Janin N., Bellet D., and Bressac B. Simple sequence repeat polymorphism within the p53 gene. Oncogene 8 (1993) 1703-1705
14. Plesants L.M., and Hansen M.F. Identification of a polymorphism in intron 2 of the p53 gene. Hum Genet 93 (1994) 607-608
15. Hillebrandt S., Streffer C., Demidchik E.P., Biko J., and Reiners C. Polymorphisms in the p53 gene in thyroid tumours and blood samples of children from areas in Belarus. Mutat Res 381 (1997) 201-207
16. Tommiska J., Eerola H., Heinonen M., Salonen L., Kaare M., Tallila J., et al. Breast cancer patients with p53 Pro 72 homozygous genotype have a poorer survival. Clin Cancer Res 11 (2005) 5098-5103
17. Fiszer-Maliszewska L., Kazanowska B., Kusnierczyk P., Manczak M., Nicpieklo W., Pachron-Zeman B., et al. Is p53 intronic variant G13964C associated with predisposition to cancer?. J Appl Genet 44 (2003) 547-552
18. Gemignani F., Moreno V., Landi S., Moullan N., Chabrier A., Gutierrez-Enriquez S., et al. TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 23 (2004) 1954-1956
19. Marsh A., Spurdle A.B., Turner B.C., Fereday S., Thorne H., Pupo G.M., et al. The intronic G13964C variant in p53 is not a high risk mutation in familial breast cancer in Australia. Breast Cancer Res 3 (2001) 346-349
20. Wu X., Zhao H., Amos C.I., Shete S., Makan N., Hong W.K., et al. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94 (2002) 681-690
21. Sayhan N., Yazici H., Budak M., Bitisik O., and Dalay N. p53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. Res Com Mol Pathol Pharmacol 109 (2001) 25-34
22. Buyru N., Tezol A., and Dalay N. p53 intronic G13964C variant in colon cancer and its association with HPV. Anticancer Res 25 (2005) 2767-2770
23. Runnebaum I.B., Tong X.W., Konig R., Zhao H., Korner K., Atkinson E.N., et al. p53 based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet 345 (1995) 994
24. Själander A., Birgander R., Hallmans G., Cajander S., Lenner P., Athlin L., et al. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17 (1996) 1313-1316
25. Birgander R., Själander A., Rannug A., Alexandrie A.K., Sundberg M.I., Seidegard J., et al. p53 poymorphisms and haplotypes in lung cancer. Carcinogenesis 16 (1995) 2233-2236
26. Själander A., Birgander R., Athlin L., Stenling R., Rutegard J., Beckman L., et al. P53 germline haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16 (1995) 1461-1464
27. Thomas M., Kalita A., Labrecque S., Pim D., Banks L., and Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19 (1999) 1092-1100
28. Buyru N., Tigli H., and Dalay N. p53 codon 72 polymorphism in breast cancer. Oncol Rep 10 (2003) 711-714
29. Pim D., and Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108 (2004) 196-199
30. Jin X., Wu X., Roth J.A., Amos C.I., King T.M., Branch C., et al. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16 (1995) 2205-2208
31. Lehman T.A., Haffty B.G., Carbone C.J., Bishop L.R., Gumbs A.A., Krishnan S., et al. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res 60 (2000) 1062-1069
32. Varley J.M., McGown G., Thorncraft M., Kelsey A.M., and Birch J.M. Significance of intron 6 sequence variations in the TP53 gene in Li-Fraumeni syndrome. Cancer Genet Cytogenet 29 (2001) 85-87
33. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16 (1988) 1215
34. Lancester J.M., Brownlee H.A., Wiseman R.W., and Taylor J. p53 poymorphism in ovarian and bladder cancer. Lancet 346 (1995) 182
35. Fan R., Wu M.T., Miller D., Wain J., Kelsey K.T., Wiencke J.K., et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9 (2000) 1037-1042
36. Lee J.M., Lee Y.C., Yang S.Y., Shi W.L., Lee C.J., Luh S.P., et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 89 (2000) 458-464
37. Papadakis E., Soulitzis N., and Spandidos D.A. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer 87 (2002) 1013-1018
38. Weston A., Pan C., Ksiesk H.B., Wallenstein S., Berkowitz G.S., Tartter P.I., et al. p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 105-112
39. Fiszer-Maliszewska L., Bebenek M., Gorski B., Kazanowska B., Kurzawski G., Sikorska A., et al. Screening for predisposing mutations in Polish families with Li-Fraumeni/Li-Fraumeni-like syndrome or with breast and ovarian cancer. Cancer Detect Prev Suppl 1 (2002) 26
40. Osorio A., Martinez-Delgado B., Pollan M., Cuadros M., Urioste M., Torrenteras C., et al. A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers. Hum Mutat 27 (2006) 242-248
41. Wang-Gohrke S., Rebbeck T.R., Bessenfelder W., Krienberg R., and Runnebaum I.B. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res 18 (1998) 2095-2099
42. Birgander R., Själander A., Zhou Z., Fan C., Beckman L., and Beckman G. p53 polymorphisms and haplotypes in nasopharyngeal cancer. Hum Hered 46 (1996) 49-54
43. Mitra S., Misra C., Singh R.K., Panda C.K., and Roychoudhury S. Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J Clin Pathol 58 (2005) 26-31
44. Biros E., Kalina I., Kohut A., Bogyiova E., Salagovic J., and Sulla I. Allelic and haplotype frequencies of the p53 polymorphisms in brain tumor patients. Physiol Res 51 (2002) 59-64